Last reviewed · How we verify
Medical treatment
Medical treatment is a Small molecule drug developed by University of Sao Paulo General Hospital. It is currently FDA-approved. Also known as: Timoptol 0,5%, Xalatan, Trusopt, Alphagan.
At a glance
| Generic name | Medical treatment |
|---|---|
| Also known as | Timoptol 0,5%, Xalatan, Trusopt, Alphagan, Duloxetine |
| Sponsor | University of Sao Paulo General Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer (PHASE2)
- Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer (PHASE2)
- Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial (PHASE1)
- Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma (PHASE3)
- Osimertinib Combined With Intracranial SRT for EGFR-Mutant NSCLC With Symptomatic Brain Metastases
- Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors (PHASE1)
- Testing Afatinib as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH - Subprotocol A) (PHASE2)
- Conservative Treatment of Trigger Finger (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Medical treatment CI brief — competitive landscape report
- Medical treatment updates RSS · CI watch RSS
- University of Sao Paulo General Hospital portfolio CI
Frequently asked questions about Medical treatment
What is Medical treatment?
Medical treatment is a Small molecule drug developed by University of Sao Paulo General Hospital.
Who makes Medical treatment?
Medical treatment is developed and marketed by University of Sao Paulo General Hospital (see full University of Sao Paulo General Hospital pipeline at /company/university-of-sao-paulo-general-hospital).
Is Medical treatment also known as anything else?
Medical treatment is also known as Timoptol 0,5%, Xalatan, Trusopt, Alphagan, Duloxetine.
What development phase is Medical treatment in?
Medical treatment is FDA-approved (marketed).
Related
- Manufacturer: University of Sao Paulo General Hospital — full pipeline
- Also known as: Timoptol 0,5%, Xalatan, Trusopt, Alphagan, Duloxetine
- Compare: Medical treatment vs similar drugs
- Pricing: Medical treatment cost, discount & access